HOME >> BIOLOGY >> NEWS
Professor calls for a new branch of learning

Nanotechnology, the 'science of small things' is set to bring huge advantages in engineering, electronics, medicine and IT-- but the potential threats to health that widespread use of nanoparticles could bring need to be scrutinised, says a University of Edinburgh expert in this month's edition of Occupational and Environmental Medicine.

Professor Ken Donaldson, a lung toxicology expert and Professor of Respiratory Medicine at the University, calls for a new discipline--nanotoxicology-- to be built up, to address knowledge gaps and to help develop a safe nanotechnology. He wants guidelines to be developed to test all materials in the nanoscale where human health could be involved.

Professor Donaldson says: "We believe that efforts to untangle science and science fiction regarding the risks from nanotechnology are needed and that a focus on the potential harmful effects of nanoparticles is both timely and necessary. The importance of nanotechnology to the economy and to our future wellbeing is beyond debate, but its potential adverse impacts need to be studied along the same lines. A discipline of nanotoxicology would make an important contribution to the development of a sustainable and safe nanotechnology .

He added: "Our current knowledge of the toxicology of nanoparticles and nanotubes (tiny carbon tubes) is poor but suggests that nanoparticles may be able to have undesirable effects at their point of entry into the body, for example, the lungs, and might also be able to affect other organs. Nanoparticles in food may cross into the gut lymphatic system and so reach other organs more easily than larger particles do. Inhaled nanoparticles have been reported to travel from nasal nerves to the brain, a phenomenon seen with some viruses similar in size to nanoparticles."

Nanoparticles, materials the size of millionths of a millimetre, are already present in large numbers in the air from natural sources and from vehicle exhaust emissio
'"/>

Contact: Linda Menzies
linda.menzies@ed.ac.uk
44-131-650-6382
University of Edinburgh
30-Aug-2004


Page: 1 2

Related biology news :

1. Professor and student among tops in technology at UH
2. Professor publishes book on historic mosquito wars
3. Professor uses satellites to protect Amazon forests, global climate
4. Sarah Billington and Alexandria Boehm named Clare Boothe Luce Assistant Professors
5. Professor develops strategies to control exotic plant species
6. LSU Professor Emeritus wins 2001 National Wetlands Award
7. Professor says college athletic departments must pay more attention to eating disorders
8. Professor Will Connect With Students Live From China Dinosaur Site
9. Wistar Institute Professor Named First Koprowski Professor
10. Virginia Tech Fisheries Professor Works To Conserve Mussels
11. Professor Authors Complete Guide To Fungi

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... 08, 2020 , ... Overcoming Comparability Issues in Regenerative Medicines ... Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy , ... way to complete one? Will the study comply with all FDA requirements? Understanding ...
(Date:7/1/2020)... N.J. (PRWEB) , ... July 01, 2020 , ... ... announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in ... the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... monoclonal antibody development services, today announced that the company has received ISO9001:2015 ... the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... (PRWEB) , ... June 30, ... ... expert tissue data insights, today announced that the launch of a new ... along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight is ...
(Date:6/28/2020)... , ... June 25, 2020 , ... ... advance photodynamic therapy for treating cancer, today announced the company has entered a ... Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the premier provider ... Derek Fournier has been appointed CEO and President. Founder and former CEO, David ... , “DeCurtis Corporation has been on an incredible journey for the last twenty ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... innovative CNS therapies, today announced that it has filed an Investigational New Drug ... Phase 2b clinical trial of its lead drug candidate NBTX-001 in patients with ...
Breaking Biology Technology:
Cached News: